Wacker Chemie AG

Wacker Chemie AG Contract Manufacturing & Development (CDMO) Profile

Wacker Biotech is partner of choice for manufacturing of biopharmaceuticals (therapeutic proteins, vaccines, live biotherapeutic products) based on microbial systems and for the entire manufacturing chain of pDNA, mRNA and lipid nanoparticle formulations. The service portfolio covers molecular biology, process development as well as GMP manufacturing for clinical and commercial supply. Our integrated service portfolio covers molecular biology, process- and analytical development as well as GMP manufacturing of biologics for clinical and commercial supply. Wacker Biotech maintains four GMP-compliant production plants in Amsterdam (The Netherlands), San Diego (US) and in the German cities of Jena and Halle. Our customers benefit from Wacker Biotech’s decades of experience in R&D and GMP solutions as a one-stop-shop for the development and GMP manufacturing of biologics at scales to meet clinical and commercial needs. Additionally, we offer our customers added value with outstanding E. coli technologies that significantly increase the bioprocess efficiency and so reduce the cost of goods.

CDMO Services:
Biologics; API and/or Ingredients; Cell & Gene Therapy Lyophilized amps/vials Analytical Development; Cell Line Development; ICH Stability Testing; Protein Synthesis; Process Development Fusion Proteins; Recombinants + other Proteins; mRNA Vaccines; Protein Vaccines; Plasmid DNA; Live Biotherapeutic Products

Year Founded: 1914

Head Office: Munich, Germany

Number of Facilities: 45415

Facility locations: North America; Europe

Website: Visit the Wacker Chemie AG website

Linkedin: Connect on Linkedin